UiPath, Inc (PATH) Launches New AI Tools for Healthcare

​UiPath, Inc. (NYSE:PATH) is one of the Best All-Time Low Stocks to Invest In Now. On February 23, UiPath, Inc. (NYSE:PATH), which is a leader in robotic process automation, launched new AI tools, particularly for healthcare, at the ViVE 2026 conference. This marks a significant step for the company as it transitions to agentic automation.

​Management noted that the AI tools target healthcare providers and insurers to fix revenue cycle headaches. The AI tools connect data silos, cut admin work, and boost cash flow. They also help in summarizing medical records, preventing claims denials, and speeding up the process of authorizations.

UiPath, Inc. (NYSE:PATH) also noted that the healthcare sector revenue cycles are faced with challenges, including labor shortage, unstructured clinical notes, and high denial rates. The recently launched tools automate these issues end-to-end, turning raw data into actionable insights while staying fully compliant.

​That said, UiPath, Inc. (NYSE:PATH) recently acquired WorkFusion to strengthen its Agentic AI Portfolio; you can read about it here.

​UiPath Inc. (NYSE:PATH) provides an end-to-end automation platform that offers a range of RPA (robotic process automation) solutions primarily in the US, Romania, the UK, the Netherlands, and internationally.

While we acknowledge the potential of PATH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.